Observational studyRevista medica del Instituto Mexicano del Seguro Social2026
Risk factors for death by COVID-19, public hospital in Ciudad Juárez, México.
Observational study in Revista medica del Instituto Mexicano del Seguro Social, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: On March 11, 2020, a COVID-19 pandemic was declared for a novel coronavirus named SARS-CoV-2 virus. This virus induces a severe inflammatory response, producing death in patients with COVID-19 disease, in México, in 2021, COVID-19 mortality becomes the second cause of death, with higher mortality in persons with previous conditions like chronic non-communicable diseases. Objective: To identify the risk factors associated with deaths in patients diagnosed with COVID-19 from January 1 to December 31, 2021, hospitalized in a clinic of IMSS in Ciudad Juárez, Chihuahua, México. Material and methods: An observational, cross-sectional, analytical study was used. Information from patients with confirmed diagnostic of COVID-19 was collected from the SINOLAVE platform and medical records. To identify risk factors, univariate and multivariate logistic regression was used. Results: A total of 277 patients were included, 51.62% were male, the rest were female. Death from COVID-19 were associated with age (OR: 1.03; 95%CI: 1.01 - 1.06, p ≤ 0.001), chronic kidney disease (OR: 3.20; 95%CI: 1.58 - 6.48, p ≤ 0.001) chronic neurological diseases (OR: 5.27; 95%CI: 1.30 - 20.03, p ≤ 0.05), and chronic obstructive pulmonary diseases (OR: 12.24; 95%CI: 1.44 - 103.82, p ≤ 0.05); the proportion of death by sex were similar in the study. Conclusion: Age, chronic kidney disease, chronic neurological disease, and chronic obstructive pulmonary diseases were associated with death in patients with COVID-19. It's important to prevent and control chronic non-communicable diseases; the distribution was similar in both sexes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.